| Entry |
|
|---|
| Name |
Alendronic acid (INN) |
|---|
| Formula |
C4H13NO7P2
|
|---|
| Exact mass |
249.0167
|
|---|
| Mol weight |
249.10
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
|
|---|
| Remark |
| Product (DG00783): | D00939<JP/US> |
| Product (mixture): | D10841<US> |
|
|---|
| Efficacy |
Antiresorptive, Farnesylpyrophosphate synthetase inhibitor |
|---|
| Comment |
Bishposphonate
|
|---|
| Target |
|
|---|
| Pathway |
| hsa00900 | Terpenoid backbone biosynthesis |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BA Bisphosphonates
M05BA04 Alendronic acid
D07119 Alendronic acid (INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
DG00783 Alendronic acid
D07119 Alendronic acid
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Alkyl/Aryl transferases
FDPS
D07119 Alendronic acid (INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG01600 Bisphosphonate
DG00783 Alendronic acid
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 14
1 P1b P 20.5100 -20.4400
2 C1d C 21.9100 -20.4400
3 C1b C 21.9100 -18.5500
4 O1a O 21.9100 -21.8400
5 P1b P 23.3100 -20.4400
6 O1c O 24.7100 -20.4400
7 O1c O 19.1100 -20.4400
8 O1c O 20.5100 -19.0400
9 O1c O 23.3100 -19.0400
10 C1b C 23.1224 -17.8500
11 C1b C 23.1225 -16.4502
12 N1a N 24.3181 -15.7598
13 O1c O 20.5100 -21.8400
14 O1c O 23.3100 -21.8400
BOND 13
1 1 2 1
2 2 3 1
3 2 4 1
4 2 5 1
5 5 6 1
6 1 7 1
7 1 8 2
8 5 9 2
9 3 10 1
10 10 11 1
11 11 12 1
12 1 13 1
13 5 14 1
|
|---|
